In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) closed at $2.05 in the last session, down -12.77% from day before closing price of $2.35. In other words, the price has decreased by -$12.77 from its previous closing price. On the day, 0.54 million shares were traded. NRXP stock price reached its highest trading level at $2.41 during the session, while it also had its lowest trading level at $2.02.
Ratios:
We take a closer look at NRXP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.20 and its Current Ratio is at 0.20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Javitt Jonathan C bought 40,000 shares for $1.17 per share. The transaction valued at 46,800 led to the insider holds 84,634 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 34676980 and an Enterprise Value of 32731788.
Stock Price History:
The Beta on a monthly basis for NRXP is 1.35, which has changed by -0.5738046 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, NRXP has reached a high of $6.01, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -30.84%, while the 200-Day Moving Average is calculated to be -5.27%.
Shares Statistics:
According to the various share statistics, NRXP traded on average about 1.21M shares per day over the past 3-months and 188600 shares per day over the past 10 days. A total of 16.92M shares are outstanding, with a floating share count of 14.03M. Insiders hold about 17.08% of the company’s shares, while institutions hold 6.33% stake in the company. Shares short for NRXP as of 1740700800 were 1169750 with a Short Ratio of 0.96, compared to 1738281600 on 1032474. Therefore, it implies a Short% of Shares Outstanding of 1169750 and a Short% of Float of 7.7800006.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of NRX Pharmaceuticals Inc (NRXP) is currently drawing attention from 1.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.22 and low estimates of -$0.22.
Analysts are recommending an EPS of between $0.02 and -$0.07 for the fiscal current year, implying an average EPS of -$0.03.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $10M. There is a high estimate of $10M for the next quarter, whereas the lowest estimate is $10M.
Based on 1 analysts’ estimates, the company’s revenue will be $180.28M in the next fiscal year. The high estimate is $180.28M and the low estimate is $180.28M.
